2013 Proves Successful Year for Bioscience in Colorado
Upcoming SlideShare
Loading in...5
×
 

2013 Proves Successful Year for Bioscience in Colorado

on

  • 131 views

Colorado BioScience Association (CBSA) highlights Colorado’s key financings and acquisitions in the industry during 2013. The Association plays a key role in promoting Colorado as a dynamic region ...

Colorado BioScience Association (CBSA) highlights Colorado’s key financings and acquisitions in the industry during 2013. The Association plays a key role in promoting Colorado as a dynamic region for bioscience innovation and investment.

Statistics

Views

Total Views
131
Slideshare-icon Views on SlideShare
131
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    2013 Proves Successful Year for Bioscience in Colorado 2013 Proves Successful Year for Bioscience in Colorado Document Transcript

    •     2013  Proves  Successful  Year  for  Bioscience  in  Colorado     Colorado  BioScience  Association  (CBSA)  highlights  Colorado’s  key  financings  and  acquisitions  in  the  industry  during   2013.    The  Association  plays  a  key  role  in  promoting  Colorado  as  a  dynamic  region  for  bioscience  innovation  and   investment.       Denver,  CO  –  December  17,  2013  –  Colorado  realized  a  number  of  key  financings  and  acquisitions  in  the  bioscience   industry  during  2013.    The  announcement  is  made  by  April  Giles,  President  &  CEO  of  the  Colorado  BioScience   Association  (CBSA),  who  says  "We  saw  several  exciting  deals  this  year  with  many  more  on  the  horizon  as  Colorado   continues  to  gain  national  recognition  in  the  bioscience  industry."     CBSA  plays  a  key  role  in  promoting  Colorado  as  a  dynamic  region  for  bioscience  innovation  and  investment,  by  working   with  government  and  community  stakeholders  to  develop  ways  to  support  the  creation,  retention  and  recruitment  of   life  sciences  companies.     Highlighted  Financing  and  Acquisitions  in  2013  Include  (deals  over  $8M):     •  Biodesix  Closes  $8.8M  Series  D  Financing  -­‐  April  11,  2013   Boulder  based  Biodesix,  Inc.,  announced  that  the  company  closed  on  $8.8  million  in  a  follow-­‐on  sale  of  its  Series  D   preferred  shares.    http://www.biodesix.com/biodesix-­‐closes-­‐series-­‐d-­‐financing-­‐2/     •  Takeda  to  Acquire  Inviragen  for  $250M  –  May  8,  2013   Fort  Collins  based  Inviragen  agreed  to  be  acquired  by  Takeda,  the  largest  pharmaceutical  company  in  Japan  for  $35   million  cash  and  $215  million  in  milestones.  http://www.takeda.com/news/2013/20130508_5757.html     •  Lanx  Completes  $15M  Series  C  Equity  Financing  –  May  13,  2012   Broomfield  based  Lanx,  Inc.,  announced  the  closing  of  a  $15  million  Series  C  equity  financing.   http://www.lanx.com/pdfs/PR9900-­‐0113_Series%20C%20Equity%20Financing%20Release.pdf     •  Clovis  Oncology  Raises  an  Additional  $275M  –  June  18,  2013   Boulder  based  Clovis  Oncology’s  initial  IPO  in  2011  was  $139  million  on  the  sale  of  10.7  million  shares.  They  raised  an   additional  $75  million  in  2012  and  $275  million  in  June  of  2013  through  public  offerings.   http://www.xconomy.com/boulder-­‐denver/2013/06/18/clovis-­‐oncology-­‐closes-­‐275m-­‐offering-­‐following-­‐two-­‐pivotal-­‐weeks/     •  SomaLogic  Inc.  Raised  $10M  in  Equity  Financing  –  August  20,  2013   Boulder  based  SomaLogic  Inc.  raised  $10  million  in  equity  financing  from  unidentified  investors.   http://www.bizjournals.com/denver/blog/boosters_bits/2013/08/somalogic-­‐raises-­‐venture-­‐capital.html     •  Baxter  Completes  Acquisition  of  Gambro  AB  for  $4B  –  September  6,  2013   Lakewood  based  Gambro  BCT,  a  wholly  owned  entity  of  Gambro  AB  was  acquired  by  Baxter  International  Inc.  of   Deerfield,  Ill  for  $4  billion.   http://www.baxter.com/press_room/press_releases/2013/09_06_13_gambro.html     •  Ampio  Pharmaceuticals,  Inc.  Announces  $25M  Financing  –  September  26,  2013   Greenwood  Village  based  Ampio  Pharmaceuticals,  Inc.  (NYSE  MKT:  AMPE)  announced  a  financing  transaction  that  will   provide  $25  million  in  gross  proceeds  to  the  company.       http://ampiopharma.com/news/ampio-­‐pharmaceuticals-­‐inc-­‐announces-­‐25-­‐million-­‐financing/     -­‐More-­‐  
    • Page  2     •  Surefire  Medical  Closes  Series  B  Funding  at  $18.2M  -­‐  November  7,  2013   Westminster  based  Surefire  Medical,  Inc.  completed  a  $18.2  million  Series  B  funding.  The  latest  financing  will  be  used  to   expand  product  development,  clinical  trials,  operations  and  marketing  to  meet  rapidly  growing  national  and   international  customer  demand.   http://surefiremedical.com/news/surefire-­‐medical-­‐closes-­‐series-­‐b-­‐funding-­‐at-­‐18-­‐2-­‐million/     “Large  financings  and  acquisitions  are  key  to  raising  Colorado’s  profile  to  garner  attention  from  investors  and  corporate   leadership.  Colorado  has  all  of  the  pieces  in  place  to  be  in  the  top  5  national  bioscience  clusters  in  the  country—  the   science,  the  infrastructure,  and  the  people,"  Giles  explains.           About  Colorado  BioScience  Association     Celebrating  ten  years  of  supporting  the  Bioscience  Industry  in  Colorado  in  2013,  the  CBSA  is  a  not-­‐for-­‐profit  organization   providing  services  and  support  for  Colorado's  bioscience  industry.  With  more  than  350  members,  CBSA  actively  works  to   promote  the  growth  of  the  industry  by  advocating  for  a  better  business  environment,  growing  the  state's  biotech   workforce,  fighting  for  policies  that  support  a  strong  bioscience  industry  in  the  state,  and  speaking  with  a  single  voice  on   behalf  of  the  industry.  For  more  information,  visit  http://www.cobioscience.com.       CBSA  also  is  found  on  these  social  media  sites:     Twitter:  http://www.twitter.com/COBioscience         LinkedIn  Group:  http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro         Facebook  Fan  Page:  http://www.facebook.com/ColoradoBioScienceAssociation     News  Feed:    http://coloradobio.blogspot.com       YouTube  Channel:  http://www.youtube.com/COBioscience       Pinterest:  http://pinterest.com/COBioscience         Tumblr:  http://cobioscience.tumblr.com         Contacts:   Mae  Desaire,  Director  of  Marketing,  Colorado  BioScience  Association  -­‐  http://www.cobioscience.com    –     720-­‐382-­‐5918,  mdesaire@cobioscience.com           Maggie  Chamberlin  Holben,  APR,  Absolutely  Public  Relations  -­‐  http://www.absolutelypr.com    -­‐  303-­‐984-­‐9801,   maggie@absolutelypr.com